Page last updated: 2024-10-26

felbamate and Bilateral Headache

felbamate has been researched along with Bilateral Headache in 3 studies

Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.

Research Excerpts

ExcerptRelevanceReference
"The usefulness of felbamate (FBM) levels in managing epilepsy patients has not been determined."7.69Felbamate levels in patients with epilepsy. ( Harden, CL; Kutt, H; Trifiletti, R, 1996)
"We prospectively investigated drug-induced headaches (HA) among 60 epileptic patients receiving felbamate (FBM)."7.69Felbamate-induced headache. ( Andriola, MR; Berdia, A; Ettinger, AB; Jandorf, L; Krupp, LB; Weisbrot, DM, 1996)
"Felbamate (FBM) pharmacokinetic parameters, safety and tolerability in the dose range of 1,200-6,000 mg/day were assessed in two open-label studies with similar designs."6.68Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy. ( Lyness, WH; Narang-Sachdeo, SK; Perhach, JL; Rosenberg, A; Sachdeo, R; Shumaker, RC, 1997)
"The usefulness of felbamate (FBM) levels in managing epilepsy patients has not been determined."3.69Felbamate levels in patients with epilepsy. ( Harden, CL; Kutt, H; Trifiletti, R, 1996)
"We prospectively investigated drug-induced headaches (HA) among 60 epileptic patients receiving felbamate (FBM)."3.69Felbamate-induced headache. ( Andriola, MR; Berdia, A; Ettinger, AB; Jandorf, L; Krupp, LB; Weisbrot, DM, 1996)
"Felbamate (FBM) pharmacokinetic parameters, safety and tolerability in the dose range of 1,200-6,000 mg/day were assessed in two open-label studies with similar designs."2.68Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy. ( Lyness, WH; Narang-Sachdeo, SK; Perhach, JL; Rosenberg, A; Sachdeo, R; Shumaker, RC, 1997)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harden, CL1
Trifiletti, R1
Kutt, H1
Ettinger, AB1
Jandorf, L1
Berdia, A1
Andriola, MR1
Krupp, LB1
Weisbrot, DM1
Sachdeo, R1
Narang-Sachdeo, SK1
Shumaker, RC1
Perhach, JL1
Lyness, WH1
Rosenberg, A1

Trials

1 trial available for felbamate and Bilateral Headache

ArticleYear
Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Epilepsia, 1997, Volume: 38, Issue:8

    Topics: Adolescent; Adult; Anorexia; Anticonvulsants; Area Under Curve; Dose-Response Relationship, Drug; Dr

1997

Other Studies

2 other studies available for felbamate and Bilateral Headache

ArticleYear
Felbamate levels in patients with epilepsy.
    Epilepsia, 1996, Volume: 37, Issue:3

    Topics: Adolescent; Anorexia; Anticonvulsants; Child; Child, Preschool; Chromatography, High Pressure Liquid

1996
Felbamate-induced headache.
    Epilepsia, 1996, Volume: 37, Issue:5

    Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Anticonvulsants; Dose-Response Relationship, Drug

1996